Care delivery · Women’s health
Almond ObGyn
A membership OB-GYN practice built to be, in its own words, “like One Medical but for women’s health,” combining a single Los Angeles clinic with telehealth. It raised a $7 million seed round in 2022 and closed the clinic in March 2026.
A membership card instead of a waiting room
Almond opened its first clinic on Melrose Avenue in Los Angeles in August 2022, fresh out of Y Combinator’s summer batch. The pitch was simple: pay an annual membership, get faster access to an OB-GYN, and use telehealth for anything that did not require a physical exam. The company said it hit a $90,000 monthly revenue run rate and was booking three weeks out before the clinic even opened its doors, according to its Y Combinator launch post.
The founders built the office themselves. In a 2024 podcast interview, Tara Raffi described a 1,000 square foot build out for about $75,000, with concrete floors, natural wood and fruit stickers at the front desk, a deliberate break from what she called the fluorescent, paper gown feel of a typical ObGyn office.
The problem it targeted
Almond’s materials cited a 2020 Commonwealth Fund report that found 75% of women in the United States are dissatisfied with their OB-GYN care, the second largest medical specialty by spend after primary care. Raffi told Forbes that OB-GYN had “zero companies delivering modern tech-enabled care,” even as venture money poured into primary care look alikes like One Medical.
The company’s answer was to take administrative and low-complexity work off physicians and hire a wider mix of care roles, including nurse midwives and physician assistants, alongside MDs. It later layered in a root cause, “functional” framing of care, and in 2024 launched a flat fee, ten session group prenatal care program and a lab-testing product called Baseline.
Two founders, a personal complaint
Tara Raffi was a McKinsey consultant who had built the firm’s internal tech incubator before starting Almond. She has said the idea traces to a frustrating search for an OB-GYN in the Bay Area for a chronic issue, and a UTI she could not get treated while working long hours inside a hospital system as a consultant. Her co-founder, Carly Allen, spent her career in CAA’s marketing division running global campaigns for brands including Coca-Cola and Nike; her late father had been an OB-GYN.
Raising money took time. Raffi told Authority Magazine it took “over 180 investor pitches” before the company closed a round, after an initial attempt at a larger raise fell short and the founders bridged with a smaller friends and family round first. The seed eventually closed with Tony Conrad of True Ventures and Brit Morin of Offline Ventures as named investors, alongside YC group partner Surbhi Sarna and advisors including Carbon Health founder Caesar Djavaherian and Modern Animal founder Steve Eidelman, per the same interview.
Growth, then a fast shutdown
By August 2024, Forbes was calling Almond “the first full-service, tech-enabled OB-GYN in the country,” and Inc. magazine named Raffi and Allen to its 2024 Female Founders 250 list. The following month, the Los Angeles Business Journal covered Almond’s launch of a $2,500 flat fee group pregnancy care program, describing the company as having “$7 million in venture funding, though it declined to name the funders.” As late as January 2025, Raffi was describing a new diagnostic testing product in a founder interview, with no public sign of trouble.
Then, in early 2026, Almond posted a letter on its website announcing the clinic would close. “The financial realities of today’s healthcare and insurance systems have made it increasingly challenging to practice medicine in a way that aligns with our values and with the level of care we believe women deserve,” the letter said. The last day for most appointments was set for March 20, 2026, with portal access and prescription support continuing through March 29. Almond arranged for patients to transition to Tia Health, and listed several of its own clinicians’ next destinations, including Cedars-Sinai, Maven Clinic and a new practice its medical director planned to open in April 2026.
What is proven, and what is still claimed
| Evidence | What the record shows | Source type |
|---|---|---|
| SEC Form D, Almond Life, Inc. | Filed Nov 23, 2022 under CIK 0001955200. Address 8274 Melrose Ave, Los Angeles. Lists year of incorporation as 2020, in Delaware. Total offering $7,203,992, total sold $7,198,993 to 42 investors, about $171,400 average. Only related persons listed are co-founders Tara Raffi and Carly Allen; no investor names appear in the filing itself. | Public record |
| Founding year | The company and Y Combinator both give 2021. The SEC filing lists 2020 as the year of incorporation. The Los Angeles Business Journal, in a September 2024 article, states Almond “was founded in 2022.” | Differs across sources |
| Seed round investors | TechCrunch and Femtech Insider named True Ventures as lead in November 2022; Forbes added Offline Ventures in August 2024; a 2024 podcast interview named Tony Conrad and Brit Morin specifically. A September 2024 Los Angeles Business Journal article says the company “declined to name the funders.” | Differs across sources |
| FDA records, federal grants, clinical trials | No FDA 510(k) or PMA filings, no NIH or NSF awards, and no registered clinical trial tied to Almond Life, Inc. or Almond ObGyn were found. Almond is a care delivery company, not a device or drug developer, so this absence is expected rather than notable. | Not applicable |
| Peer-reviewed literature | No PubMed-indexed paper naming the company or its founders was found as of Sep 25, 2026. | Not found |
| Provider registry | No organizational NPI record for “Almond ObGyn” or “Almond Life” was found in the NPI registry as of Sep 2026, suggesting clinicians were credentialed individually rather than under a group organizational NPI, or that the group used a name not searched here. | Not found |
| Closure | The company posted its own closure letter in early 2026, setting March 20, 2026 as the last day for most appointments. Yelp and MapQuest both list the Melrose Avenue location as permanently closed. No independent news article reporting on the shutdown was found. | Company-stated |
Read plainly: the underlying facts of Almond’s business, one clinic, one membership model, one Form D, are on the record. What is not on the record, or not consistent across the record, is the founding date and exactly who backed the company, since press accounts named investors that the company itself later declined to confirm. There is also no independent account of why the business closed beyond the company’s own letter.
What to watch
- Where Almond’s clinicians land. The closure letter names several, including a medical director planning her own practice starting April 2026.
- Whether any independent reporting on the shutdown, or on what happened to the roughly $7.2M raised, appears after this closure.
- Whether an amended or later Form D ever surfaces for Almond Life, Inc.; none has as of September 2026.
In their words
“The patient experience today is slow, it’s incomplete, and ultimately it’s delivering not great outcomes. We are under-delivering as a country. [Almond] is coming in and modernizing the OB-GYN office.”
Tara Raffi, co-founder and CEO, TechCrunch, Nov 22, 2022 · Independent
“The overturning of Roe is a reminder that women still aren’t given the right to be decision-makers of their own bodies. That is infuriating.”
Tara Raffi, TechCrunch, Nov 22, 2022 · Independent
“We have a chronic disease crisis in this country that affects women differently. There is so much attention and funding in the primary care space. There were zero companies delivering modern tech-enabled care in OB-GYN, which is not a small niche.”
Tara Raffi, Forbes, Aug 15, 2024 · Independent
“Together with our expert team, we build a supportive nest that delivers better outcomes.”
Tara Raffi, Los Angeles Business Journal, Sep 30, 2024 · Independent
“It took over 180 investor pitches before we got a big yes.”
Tara Raffi, Authority Magazine, Jan 8, 2025 · Interview
“We found great investors, Brit Morin at Offline Ventures, Tony Conrad at True Ventures, Surbhi Sarna at Y Combinator.”
Tara Raffi, SURROUND, The Design Board podcast, Nov 20, 2024 · Interview
“The financial realities of today’s healthcare and insurance systems have made it increasingly challenging to practice medicine in a way that aligns with our values and with the level of care we believe women deserve.”
Almond ObGyn team, closure letter, almondobgyn.com, early 2026 · Company statement
“We hope that everyone who experienced Almond carries forward this truth: women deserve truly thorough, compassionate care.”
Almond ObGyn team, closure letter, almondobgyn.com, early 2026 · Company statement
Related companies
Sources
- Public recordForm D, Almond Life, Inc., CIK 0001955200
- IndependentAlmond launches full-service OB-GYN care to rebuild patient experience
- IndependentY-Combinator Alum Almond Raises $7M to Pursue Its Vision of Holistic OB/GYN Care
- IndependentMeet Almond. The First Full-Service, Tech-Enabled OB-GYN In The Country
- IndependentOBGYN Startup Gets Into Group Pregnancy Care
- InterviewFemale Disruptors: Tara Raffi of Almond ObGyn On The Three Things You Need To Shake Up Your Industry
- InterviewBreaking Barriers in Women’s Healthcare with Almond ObGyn
- IndependentTara Raffi, Founder and CEO of Almond ObGyn, profile
- IndependentAlmond company profile
- IndependentAlmond ObGyn, Los Angeles, listing marked permanently closed
- IndependentAlmond ObGyn, 8274 Melrose Ave, listing marked permanently closed
- IndependentAlmond organization profile
- Public recordNPI Registry search for organizational records matching “Almond”
- CompanyAlmond: We make it easy to get great ObGyn care, launch post
- CompanyAlmond ObGyn closure letter and FAQ
- CompanyOur mission
- CompanyWho We Are
Profile researched and written by Healthcare Discovery. Last updated September 29, 2026.
